Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-06

AUTHORS

V Jenkins, S Catt, S Banerjee, C Gourley, A Montes, I Solis-Trapala, K Monson, L Fallowfield

ABSTRACT

BACKGROUND: Most patients presenting with advanced ovarian cancer (AOC) eventually relapse. Symptom palliation, maintenance of quality of life (QoL) and prolongation of life are primary therapeutic goals. METHODS: Sixty-six U.K. oncologists completed an online survey about AOC management. Two hundred and two patients were interviewed about care, treatment experiences and expectations. RESULTS: Prior to diagnosis, 34% (69 out of 202) of women had > or =3 symptoms associated with AOC. Twenty-one per cent (43 out of 202) thought poor symptom recognition by general practitioners (GPs) delayed diagnosis. Amelioration of side effects experienced was variable, for example, only 54% (68 out of 127) distressed by alopecia had received sufficient information about it. Clinicians were asked 'What minimum gain in progression-free survival (PFS) would make you feel it worthwhile to offer maintenance therapy?'; 48% (24 out of 50) indicated 5-6 months, but 52% (26 out of 50) believed patients would find PFS of 3-4 months acceptable. When patients were presented with hypothetical scenarios, 33% (52 out of 160) would require 1-2 months extra life, 6% (10 out of 160) 3-4 months, 31% (49 out of 160) 5-6 months, and 31% (49 out of 160) > or =7 months. However, 86% (173 out of 202) would accept treatment that improved QoL without prolongation of life. When asked what was most important, 33% (67 out of 201) said QoL, 9% (19 out of 201) length of life and 57% (115 out of 201) said both were equally important. CONCLUSION: Clinicians' and patients' experiences, expectations and priorities about OC management may differ. More... »

PAGES

2264

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.2013.223

DOI

http://dx.doi.org/10.1038/bjc.2013.223

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037135938

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23652312


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medical Oncology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Acceptance of Health Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Patterns, Physicians'", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United Kingdom", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Sussex", 
          "id": "https://www.grid.ac/institutes/grid.12082.39", 
          "name": [
            "Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jenkins", 
        "givenName": "V", 
        "id": "sg:person.0673006157.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673006157.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Sussex", 
          "id": "https://www.grid.ac/institutes/grid.12082.39", 
          "name": [
            "Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Catt", 
        "givenName": "S", 
        "id": "sg:person.01055347757.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055347757.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Royal Marsden NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "The Royal Marsden NHS Foundation Trust Chelsea and SuttonDowns RdSM2 5PT, Fulham Road, London SW3 6JJ, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Banerjee", 
        "givenName": "S", 
        "id": "sg:person.01326353035.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326353035.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Edinburgh Cancer Research Centre, MRC IGMM, Western General Hospital, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gourley", 
        "givenName": "C", 
        "id": "sg:person.01133242061.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133242061.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Guy's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.239826.4", 
          "name": [
            "Medical Oncology, Guy\u2019s Hospital, 4th Floor, Bermondsey Wing, St Thomas\u2019 Street, London SE1 9RT, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montes", 
        "givenName": "A", 
        "id": "sg:person.01366007735.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366007735.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Sussex", 
          "id": "https://www.grid.ac/institutes/grid.12082.39", 
          "name": [
            "Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Solis-Trapala", 
        "givenName": "I", 
        "id": "sg:person.0631312161.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631312161.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Sussex", 
          "id": "https://www.grid.ac/institutes/grid.12082.39", 
          "name": [
            "Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Monson", 
        "givenName": "K", 
        "id": "sg:person.01131300462.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131300462.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Sussex", 
          "id": "https://www.grid.ac/institutes/grid.12082.39", 
          "name": [
            "Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fallowfield", 
        "givenName": "L", 
        "id": "sg:person.01063165262.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063165262.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70567-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000201906"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)62231-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003353087"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23968", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004226101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2011.156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008255824", 
          "https://doi.org/10.1038/nrclinonc.2011.156"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/gyno.1996.0244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017306551"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14733140701346156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020801162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2008.09.036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025351802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2010.06.118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025506932"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70590-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026690390"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002820-200605000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033203492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejon.2008.06.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033548221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.4411", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034548245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.4411", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034548245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.33.2668", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034865088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1104390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035779003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1104390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035779003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(03)00307-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039407541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(03)00307-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039407541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/gyno.2002.6748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052005124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1103799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052109861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1103799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052109861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/85.5.365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059818446"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-06", 
    "datePublishedReg": "2013-06-01", 
    "description": "BACKGROUND: Most patients presenting with advanced ovarian cancer (AOC) eventually relapse. Symptom palliation, maintenance of quality of life (QoL) and prolongation of life are primary therapeutic goals.\nMETHODS: Sixty-six U.K. oncologists completed an online survey about AOC management. Two hundred and two patients were interviewed about care, treatment experiences and expectations.\nRESULTS: Prior to diagnosis, 34% (69 out of 202) of women had > or =3 symptoms associated with AOC. Twenty-one per cent (43 out of 202) thought poor symptom recognition by general practitioners (GPs) delayed diagnosis. Amelioration of side effects experienced was variable, for example, only 54% (68 out of 127) distressed by alopecia had received sufficient information about it. Clinicians were asked 'What minimum gain in progression-free survival (PFS) would make you feel it worthwhile to offer maintenance therapy?'; 48% (24 out of 50) indicated 5-6 months, but 52% (26 out of 50) believed patients would find PFS of 3-4 months acceptable. When patients were presented with hypothetical scenarios, 33% (52 out of 160) would require 1-2 months extra life, 6% (10 out of 160) 3-4 months, 31% (49 out of 160) 5-6 months, and 31% (49 out of 160) > or =7 months. However, 86% (173 out of 202) would accept treatment that improved QoL without prolongation of life. When asked what was most important, 33% (67 out of 201) said QoL, 9% (19 out of 201) length of life and 57% (115 out of 201) said both were equally important.\nCONCLUSION: Clinicians' and patients' experiences, expectations and priorities about OC management may differ.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.2013.223", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2753285", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.5145844", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2784285", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "108"
      }
    ], 
    "name": "Patients\u2019 and oncologists\u2019 views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study", 
    "pagination": "2264", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b0e72fdeeaaf331c7b566a51acb0048586825543dff0c33ba491941b57c308a3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23652312"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.2013.223"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037135938"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.2013.223", 
      "https://app.dimensions.ai/details/publication/pub.1037135938"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000437.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc2013223"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.223'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.223'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.223'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2013.223'


 

This table displays all metadata directly associated to this object as RDF triples.

239 TRIPLES      21 PREDICATES      60 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.2013.223 schema:about N03e01ad504114281b32351b495c4d4fd
2 N1881f14c56e14f1db149e6f46d28758d
3 N19e86b888b0a46afa0e87a64a3a4881e
4 N2c7080fbdfe84c7e9426d3797cf594fd
5 N3a931a6fe2a1451588da73678ce4bd34
6 N454a5cd1aa6349be8ecbf22d8d989165
7 N52b186773d7c431d87cef1186b03fde5
8 N65234bfdfe0c4a9fa87234107dd018be
9 N84cdb78a75374ebf842928511550ae6d
10 N991582be66f34d5c951dda128cc7755d
11 Na2c5b2a290ac48c5b8955a5b644bc6b1
12 Nca908037c4b342de9215d59ba95a5708
13 Nff96c22e9f684439a0c2da2db395ad09
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nea84d33a4057408895fa25b899eeee0e
17 schema:citation sg:pub.10.1038/nrclinonc.2011.156
18 https://doi.org/10.1002/cncr.23968
19 https://doi.org/10.1006/gyno.1996.0244
20 https://doi.org/10.1006/gyno.2002.6748
21 https://doi.org/10.1016/j.ejca.2010.06.118
22 https://doi.org/10.1016/j.ejon.2008.06.002
23 https://doi.org/10.1016/j.ygyno.2008.09.036
24 https://doi.org/10.1016/s0140-6736(10)62231-3
25 https://doi.org/10.1016/s0959-8049(03)00307-1
26 https://doi.org/10.1016/s1470-2045(12)70567-3
27 https://doi.org/10.1016/s1470-2045(12)70590-9
28 https://doi.org/10.1056/nejmoa1103799
29 https://doi.org/10.1056/nejmoa1104390
30 https://doi.org/10.1080/14733140701346156
31 https://doi.org/10.1093/jnci/85.5.365
32 https://doi.org/10.1097/00002820-200605000-00003
33 https://doi.org/10.1200/jco.2010.33.2668
34 https://doi.org/10.1200/jco.2011.39.4411
35 schema:datePublished 2013-06
36 schema:datePublishedReg 2013-06-01
37 schema:description BACKGROUND: Most patients presenting with advanced ovarian cancer (AOC) eventually relapse. Symptom palliation, maintenance of quality of life (QoL) and prolongation of life are primary therapeutic goals. METHODS: Sixty-six U.K. oncologists completed an online survey about AOC management. Two hundred and two patients were interviewed about care, treatment experiences and expectations. RESULTS: Prior to diagnosis, 34% (69 out of 202) of women had > or =3 symptoms associated with AOC. Twenty-one per cent (43 out of 202) thought poor symptom recognition by general practitioners (GPs) delayed diagnosis. Amelioration of side effects experienced was variable, for example, only 54% (68 out of 127) distressed by alopecia had received sufficient information about it. Clinicians were asked 'What minimum gain in progression-free survival (PFS) would make you feel it worthwhile to offer maintenance therapy?'; 48% (24 out of 50) indicated 5-6 months, but 52% (26 out of 50) believed patients would find PFS of 3-4 months acceptable. When patients were presented with hypothetical scenarios, 33% (52 out of 160) would require 1-2 months extra life, 6% (10 out of 160) 3-4 months, 31% (49 out of 160) 5-6 months, and 31% (49 out of 160) > or =7 months. However, 86% (173 out of 202) would accept treatment that improved QoL without prolongation of life. When asked what was most important, 33% (67 out of 201) said QoL, 9% (19 out of 201) length of life and 57% (115 out of 201) said both were equally important. CONCLUSION: Clinicians' and patients' experiences, expectations and priorities about OC management may differ.
38 schema:genre research_article
39 schema:inLanguage en
40 schema:isAccessibleForFree true
41 schema:isPartOf N2e96594b256a4041a91061af2ecbf025
42 Nffeafeb13054493d8f153e2b370b4e43
43 sg:journal.1017082
44 schema:name Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: results from the ADVOCATE study
45 schema:pagination 2264
46 schema:productId N0cb01f350132416c912921e9f69dc196
47 N37773b8cdd7b47188c51bb6c5578378c
48 N9f092012094f4abfbdb998d4b78a53ad
49 Na78444e57b5a45e0b0597be9899732ff
50 Ncd9eae516b3e438786bd52d33fed8c99
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037135938
52 https://doi.org/10.1038/bjc.2013.223
53 schema:sdDatePublished 2019-04-11T00:05
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N61619ec920054addaa71dd2c53bcd9c6
56 schema:url https://www.nature.com/articles/bjc2013223
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N03e01ad504114281b32351b495c4d4fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
61 schema:name Survival Rate
62 rdf:type schema:DefinedTerm
63 N0cb01f350132416c912921e9f69dc196 schema:name dimensions_id
64 schema:value pub.1037135938
65 rdf:type schema:PropertyValue
66 N0db6083c38614ad6be1cc5a0f43da030 rdf:first sg:person.01366007735.52
67 rdf:rest N87bc5bf91e804f0d8d0a05a11c364bf9
68 N1881f14c56e14f1db149e6f46d28758d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Patient Acceptance of Health Care
70 rdf:type schema:DefinedTerm
71 N19e86b888b0a46afa0e87a64a3a4881e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Humans
73 rdf:type schema:DefinedTerm
74 N2c7080fbdfe84c7e9426d3797cf594fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name United Kingdom
76 rdf:type schema:DefinedTerm
77 N2e96594b256a4041a91061af2ecbf025 schema:volumeNumber 108
78 rdf:type schema:PublicationVolume
79 N37773b8cdd7b47188c51bb6c5578378c schema:name nlm_unique_id
80 schema:value 0370635
81 rdf:type schema:PropertyValue
82 N3a931a6fe2a1451588da73678ce4bd34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Medical Oncology
84 rdf:type schema:DefinedTerm
85 N454a5cd1aa6349be8ecbf22d8d989165 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Quality of Life
87 rdf:type schema:DefinedTerm
88 N52b186773d7c431d87cef1186b03fde5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Surveys and Questionnaires
90 rdf:type schema:DefinedTerm
91 N52fa36a40cba479ebe7a412c0ea8e0fd rdf:first sg:person.01326353035.21
92 rdf:rest Naf753f0ec6a44fc78ee3c7676362c9d5
93 N61619ec920054addaa71dd2c53bcd9c6 schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N65234bfdfe0c4a9fa87234107dd018be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Disease-Free Survival
97 rdf:type schema:DefinedTerm
98 N6c29b41643cc4be1a925b96e4a9b5ee9 rdf:first sg:person.01131300462.49
99 rdf:rest Nd99483f380de4548a44522a3b5960db0
100 N84cdb78a75374ebf842928511550ae6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Ovarian Neoplasms
102 rdf:type schema:DefinedTerm
103 N87bc5bf91e804f0d8d0a05a11c364bf9 rdf:first sg:person.0631312161.63
104 rdf:rest N6c29b41643cc4be1a925b96e4a9b5ee9
105 N8851e292da364d9ba59983ccea4bb5a9 schema:name Edinburgh Cancer Research Centre, MRC IGMM, Western General Hospital, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK
106 rdf:type schema:Organization
107 N991582be66f34d5c951dda128cc7755d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Male
109 rdf:type schema:DefinedTerm
110 N9f092012094f4abfbdb998d4b78a53ad schema:name readcube_id
111 schema:value b0e72fdeeaaf331c7b566a51acb0048586825543dff0c33ba491941b57c308a3
112 rdf:type schema:PropertyValue
113 Na2c5b2a290ac48c5b8955a5b644bc6b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Female
115 rdf:type schema:DefinedTerm
116 Na78444e57b5a45e0b0597be9899732ff schema:name doi
117 schema:value 10.1038/bjc.2013.223
118 rdf:type schema:PropertyValue
119 Naf753f0ec6a44fc78ee3c7676362c9d5 rdf:first sg:person.01133242061.01
120 rdf:rest N0db6083c38614ad6be1cc5a0f43da030
121 Nca908037c4b342de9215d59ba95a5708 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Middle Aged
123 rdf:type schema:DefinedTerm
124 Ncd9eae516b3e438786bd52d33fed8c99 schema:name pubmed_id
125 schema:value 23652312
126 rdf:type schema:PropertyValue
127 Nce6d62b83cc94deaba790dea772c3c05 rdf:first sg:person.01055347757.29
128 rdf:rest N52fa36a40cba479ebe7a412c0ea8e0fd
129 Nd99483f380de4548a44522a3b5960db0 rdf:first sg:person.01063165262.37
130 rdf:rest rdf:nil
131 Nea84d33a4057408895fa25b899eeee0e rdf:first sg:person.0673006157.77
132 rdf:rest Nce6d62b83cc94deaba790dea772c3c05
133 Nff96c22e9f684439a0c2da2db395ad09 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Practice Patterns, Physicians'
135 rdf:type schema:DefinedTerm
136 Nffeafeb13054493d8f153e2b370b4e43 schema:issueNumber 11
137 rdf:type schema:PublicationIssue
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
142 schema:name Oncology and Carcinogenesis
143 rdf:type schema:DefinedTerm
144 sg:grant.2753285 http://pending.schema.org/fundedItem sg:pub.10.1038/bjc.2013.223
145 rdf:type schema:MonetaryGrant
146 sg:grant.2784285 http://pending.schema.org/fundedItem sg:pub.10.1038/bjc.2013.223
147 rdf:type schema:MonetaryGrant
148 sg:grant.5145844 http://pending.schema.org/fundedItem sg:pub.10.1038/bjc.2013.223
149 rdf:type schema:MonetaryGrant
150 sg:journal.1017082 schema:issn 0007-0920
151 1532-1827
152 schema:name British Journal of Cancer
153 rdf:type schema:Periodical
154 sg:person.01055347757.29 schema:affiliation https://www.grid.ac/institutes/grid.12082.39
155 schema:familyName Catt
156 schema:givenName S
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055347757.29
158 rdf:type schema:Person
159 sg:person.01063165262.37 schema:affiliation https://www.grid.ac/institutes/grid.12082.39
160 schema:familyName Fallowfield
161 schema:givenName L
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063165262.37
163 rdf:type schema:Person
164 sg:person.01131300462.49 schema:affiliation https://www.grid.ac/institutes/grid.12082.39
165 schema:familyName Monson
166 schema:givenName K
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01131300462.49
168 rdf:type schema:Person
169 sg:person.01133242061.01 schema:affiliation N8851e292da364d9ba59983ccea4bb5a9
170 schema:familyName Gourley
171 schema:givenName C
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133242061.01
173 rdf:type schema:Person
174 sg:person.01326353035.21 schema:affiliation https://www.grid.ac/institutes/grid.5072.0
175 schema:familyName Banerjee
176 schema:givenName S
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326353035.21
178 rdf:type schema:Person
179 sg:person.01366007735.52 schema:affiliation https://www.grid.ac/institutes/grid.239826.4
180 schema:familyName Montes
181 schema:givenName A
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366007735.52
183 rdf:type schema:Person
184 sg:person.0631312161.63 schema:affiliation https://www.grid.ac/institutes/grid.12082.39
185 schema:familyName Solis-Trapala
186 schema:givenName I
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631312161.63
188 rdf:type schema:Person
189 sg:person.0673006157.77 schema:affiliation https://www.grid.ac/institutes/grid.12082.39
190 schema:familyName Jenkins
191 schema:givenName V
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673006157.77
193 rdf:type schema:Person
194 sg:pub.10.1038/nrclinonc.2011.156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008255824
195 https://doi.org/10.1038/nrclinonc.2011.156
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1002/cncr.23968 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004226101
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1006/gyno.1996.0244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017306551
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1006/gyno.2002.6748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052005124
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.ejca.2010.06.118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025506932
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.ejon.2008.06.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033548221
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/j.ygyno.2008.09.036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025351802
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/s0140-6736(10)62231-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003353087
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/s0959-8049(03)00307-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039407541
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/s1470-2045(12)70567-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000201906
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/s1470-2045(12)70590-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026690390
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1056/nejmoa1103799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052109861
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1056/nejmoa1104390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035779003
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1080/14733140701346156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020801162
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1093/jnci/85.5.365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059818446
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1097/00002820-200605000-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033203492
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1200/jco.2010.33.2668 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034865088
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1200/jco.2011.39.4411 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034548245
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.12082.39 schema:alternateName University of Sussex
232 schema:name Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 9QG, UK
233 rdf:type schema:Organization
234 https://www.grid.ac/institutes/grid.239826.4 schema:alternateName Guy's Hospital
235 schema:name Medical Oncology, Guy’s Hospital, 4th Floor, Bermondsey Wing, St Thomas’ Street, London SE1 9RT, UK
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.5072.0 schema:alternateName Royal Marsden NHS Foundation Trust
238 schema:name The Royal Marsden NHS Foundation Trust Chelsea and SuttonDowns RdSM2 5PT, Fulham Road, London SW3 6JJ, UK
239 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...